AzTrials
AzTrials

Tracheal Intubation MorbiditySMURIDSNCT03486171

Tracheal Intubation and Prehospital Emergency Setting

An observational study of Tracheal Intubation Morbidity and Emergency Medicine, run by University Hospital, Bordeaux at 5 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In prehospital emergency setting, tracheal intubation is a frequent procedure (8% of interventions). Its objective is to control and protect upper airways and to optimize ventilation and oxygenation in patients with life-threatening distress. Read more about this study

Who is it for?
Ages 10 years and older
How many people
1,200 participants
Where
5 sitesFrance
Study dates
1 Mar 2017to 1 Sep 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: All patients with life-threatening distress requiring emergency intubation.

Who may be able to join

  • all patients intubated by Emergency Medical System (EMS) team

Who cannot join

  • none

Trial locations and contacts

5 sites in 1 country.

MICHEL GALINSKI, M.D; Ph.D. contact

+335.56.79.48.26

michel.galinski@chu-bordeaux.fr

MICHEL GALINSKI contact

+33678549415

5 sites in 1 country

France5 sites, 5 recruiting
  • CHU DE BORDEAUX- Hôpital PELLEGRIN - SAMU-SMUR 33

    Bordeaux, 33000

    MICHEL GALINSKI, M.D, Ph.D, +335.56.79.48.26, michel.galinski@chu-bordeaux.fr

    MICHEL GALINSKI, M.D, Ph.D

    Recruiting
  • Aphp, Hopital Raymond Poincare - Samu-Smur 92

    Garches, 92380

    PAUL-GEORGES REUTER

    PAUL-GEORGES REUTER, M.D, MSc

    Recruiting
  • Ch Garges Les Gonesses

    Garges-lès-Gonesse, 95141

    MIRKO RUSCEV

    MIRKO RUSCEV, M.D

    Recruiting
  • Chu de Grenoble - Samu-Smur 38

    Grenoble, 38000

    GUILLAUME DEBATY

    GUILLAUME DEBATY, M.D, Ph.D

    Recruiting
  • Ch de Perigueux - Samu-Smur 24

    Périgueux, 24000

    JEAN-PAUL LORENDEAU

    JEAN-PAUL LORENDEAU, M.D

    Recruiting

Other trials in France

About this study

Official title: Quality of Tracheal Intubation in Prehospital Emergency Setting and Measurement of Risk Factors of Difficult Intubation in This Context

In prehospital emergency setting, tracheal intubation is a frequent procedure (8% of interventions). Its objective is to control and protect upper airways and to optimize ventilation and oxygenation in patients with life-threatening distress. Intubation is a technical procedure which is associated with few difficulties with, in rare cases, the impossibility to do it. There are specificities of the out-of-hospital emergency with some risk factors that have been recognized in this context as well as the impossibility of assessing predictive factors of difficult intubation linked to the patient. The objective of the investigators was to describe the quality of tracheal intubation in prehospital emergency setting.

Read the detailed description

National and international guidelines have the objective to optimize the airway management modalities and to minimize the risk of complications in relation to this procedure. In contrast to the operating-room where intubation is performed daily in standardized conditions, in prehospital emergency setting, the environment and circumstances are variable and have an impact on the gesture as has been demonstrated. However, there are few studies about this issue, and these one are relatively ancients although that orotracheal intubation procedures in emergency are now well defined and that the algorithms for the management of difficult intubation have been well diffused in the emergency area these last 10 years. The last study about this topic has been published in 2012 involving more than 600 patients included between 2008 and 2010.

Difficult intubation rate, defined with a number of attempts over 2 or the use of an alternative technic was 11%. Another study with more than 2000 patients had found a rate of 6%. A study comparing the intubation difficulty scale score between two types of blades in 800 patients had found a rate of difficult intubation from 9 to 12%. The algorithms of the management of difficult intubation were largely based on the result of studies performed by anesthesiologists in operating ward. The objective will be to describe the quality of intubation and to measure risk factors of difficult intubation. The investigators are going to collect data about all patients intubated in prehospital emergency setting with the objective to measure the difficult intubation rate and to describe variables associated with difficult intubation. The follow up will be restricted to the area of prehospital emergency setting.

Keywords
difficult intubation, prehospital emergency, risk factors

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difficult intubation rate

    Difficult intubation is defined with an Intubation Difficult Scale score > 5; Intubation Difficult Sale (IDS) is ranged from 0 (easy intubation) to infinity (impossibility to intubate trachea).

    Measured: One hour

Secondary outcomes (3)
  1. Risk factors of difficult intubation

    Circumstances of intubation (outside/inside), patient on the floor or not, cardiac arrest or not and if yes resuscitation during the intubation or not, nature of the drugs for sedation during rapid sequence induction, pharyngeal or laryngeal hemorrhage.

    Measured: one hour

  2. Patient characteristics

    sex , age, body mass index, acute disease (trauma or medical), criteria associated with difficult airway access (mouth opening, thyroid-chin distance, neck circumference), pharyngeal or laryngeal tumor.

    Measured: one hour

  3. Events during and after intubation

    desaturation, vomiting, low blood pressure, tachycardia or bradycardia, cardiac arrest, others.

    Measured: one hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2018
  2. Study start1 Mar 2017
  3. Primary completion31 May 2018 (estimated)
  4. Study completion1 Sep 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03486171
Sponsor's protocol ID
CHUBX-URG-01
Acronym
SMURIDS
Status last verified
Mar 2018
First submitted
24 Jan 2018
Last updated
3 Apr 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Tracheal Intubation Morbidity and Emergency Medicine, run by University Hospital, Bordeaux at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact MICHEL GALINSKI, M.D; Ph.D. (+335.56.79.48.26, michel.galinski@chu-bordeaux.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difficult intubation rate (time frame: One hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in